T. Rowe Price Associates’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,000
Closed -$84K 3049
2024
Q3
$84K Buy
+24,000
New +$84K ﹤0.01% 2852